Brandywine Global Investment Management LLC lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 109,889 shares of the company’s stock after selling 4,614 shares during the period. Brandywine Global Investment Management LLC owned 0.08% of Henry Schein worth $8,153,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in HSIC. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Henry Schein by 4.3% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,566 shares of the company’s stock valued at $316,000 after acquiring an additional 187 shares during the period. Rockefeller Capital Management L.P. grew its position in shares of Henry Schein by 27.3% during the 1st quarter. Rockefeller Capital Management L.P. now owns 4,520 shares of the company’s stock worth $312,000 after buying an additional 970 shares during the period. Teacher Retirement System of Texas grew its position in shares of Henry Schein by 23.0% during the 1st quarter. Teacher Retirement System of Texas now owns 15,655 shares of the company’s stock worth $1,084,000 after buying an additional 2,925 shares during the period. UBS Group AG grew its position in shares of Henry Schein by 280.7% during the 1st quarter. UBS Group AG now owns 116,208 shares of the company’s stock worth $8,046,000 after buying an additional 85,686 shares during the period. Finally, E Fund Management Co. Ltd. acquired a new position in shares of Henry Schein during the 1st quarter worth about $115,000. Institutional investors own 93.16% of the company’s stock.
HSIC stock opened at $77.72 on Thursday. The company has a current ratio of 1.79, a quick ratio of 0.98 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $10.86 billion, a PE ratio of 18.29, a PEG ratio of 1.32 and a beta of 0.88. Henry Schein, Inc. has a 1-year low of $59.44 and a 1-year high of $83.45. The business’s 50 day simple moving average is $77.20 and its 200 day simple moving average is $76.15.
Several equities analysts have recently weighed in on the company. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating and set a $82.00 price objective on the stock. in a report on Tuesday, October 5th. Barrington Research boosted their target price on Henry Schein from $91.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 4th. Finally, Piper Sandler boosted their target price on Henry Schein from $89.00 to $95.00 and gave the company an “overweight” rating in a research note on Tuesday, August 3rd. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Henry Schein has a consensus rating of “Buy” and a consensus target price of $90.50.
Henry Schein Profile
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
See Also: What is a conference call?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.